SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-14-360876
Filing Date
2014-10-01
Accepted
2014-10-01 16:40:19
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d796419ds3.htm S-3 300748
2 EX-1.2 d796419dex12.htm EX-1.2 146356
3 EX-4.2 d796419dex42.htm EX-4.2 278994
4 EX-5.1 d796419dex51.htm EX-5.1 24096
5 EX-5.2 d796419dex52.htm EX-5.2 12998
6 EX-12.1 d796419dex121.htm EX-12.1 20116
7 EX-23.3 d796419dex233.htm EX-23.3 1406
8 EX-25.1 d796419dex251.htm EX-25.1 125405
9 GRAPHIC g796419111.jpg GRAPHIC 7967
10 GRAPHIC g796419222.jpg GRAPHIC 6086
11 GRAPHIC g796419g80l00.jpg GRAPHIC 39762
  Complete submission text file 0001193125-14-360876.txt   985828
Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Filer) CIK: 0001385228 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-199105 | Film No.: 141133574
SIC: 2834 Pharmaceutical Preparations